A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale-Reference-Cited by-同舟云学术

A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale

Published:2020-12-22 Issue:5 Volume:15 Page:1315-1325
ISSN:1751-7885
Container-title:Early Intervention in Psychiatry
language:en
Short-container-title:Early Intervention in Psychiatry

Author:

Keefe Richard S. E.¹²^ORCID,Woods Scott W.³,Cannon Tyrone D.³⁴,Ruhrmann Stephan⁵,Mathalon Daniel H.⁶,McGuire Philip⁷,Rosenbrock Holger⁸,Daniels Kristen⁹,Cotton Daniel⁹,Roy Dooti⁹,Pollentier Stephane¹⁰,Sand Michael⁹

Affiliation:

1. Department of Psychiatry and Behavioral Sciences Duke University Durham North Carolina USA

2. VeraSci Durham NC USA

3. Department of Psychiatry Yale University New Haven Connecticut USA

4. Department of Psychology Yale University New Haven Connecticut USA

5. Department of Psychiatry and Psychotherapy University of Cologne Cologne Germany

6. Department of Psychology UCSF School of Medicine San Francisco California USA

7. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK

8. Boehringer Ingelheim Pharma GmbH & Co KG Biberach an der Riss Germany

9. Boehringer Ingelheim Pharmaceuticals Inc. Ridgefield Connecticut USA

10. Boehringer Ingelheim International GmbH Ingelheim Germany

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eip.13083

Reference61 articles.

1. At Clinical High Risk for Psychosis: Outcome for Nonconverters

2. Diagnostic and Statistical Manual of Mental Disorders

3. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

4. Validation of the tablet-administered Brief Assessment of Cognition (BAC App)

5. Automated analysis of free speech predicts psychosis onset in high-risk youths

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential;European Journal of Medicinal Chemistry;2023-11

2. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS;Early Intervention in Psychiatry;2023-08-28

3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS;2023-05-02

4. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia;CNS Drugs;2022-07-13